BBC examines 'huge imbalance' between funding for HIV/AIDS, other health needs in Uganda

The BBC examines the balance between funding for HIV/AIDS and for the broader health system and other diseases in Uganda.

According to the BBC, organizations addressing HIV/AIDS in Uganda receive support, in part, from PEPFAR, adding, "In 2008 alone, funding from PEPFAR reached $283.6 million - an amount which easily exceeds the entire annual budget for Uganda's ministry of health."

"Many people in the West believe that all Africans are impoverished and infected with HIV" even though "many countries have stable HIV statistics of under 3%," Daniel Halperin, of Harvard, said. "But in spite of this, the vast majority of support, particularly from the U.S., is given specifically to the war on AIDS," the BBC writes.

According to the news service, Premila Bartlett, PEPFAR's coordinator in Uganda, said that the program is trying to help fix the country's health system which "in many cases is in pieces" (Villadsen, 10/4).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New two-dose HIV vaccine strategy shows promise for stronger immune response